Daniel J. Fernandes
Fondatore presso CharlestonPharma LLC
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Bradford Goodwin | M | 69 |
CharlestonPharma LLC
 CharlestonPharma LLC Medical SpecialtiesHealth Technology CharlestonPharma LLC develops therapeutic antibodies and related diagnostic tests for cancer patients and healthcare providers. It develops an obtained in vitro, ex vivo and in vivo proof of concept for its first-in-class fully human monoclonal antibodies that specifically target nucleolin located in the plasma membrane and cytoplasm of tumor cells. The company was founded by Bradford S. Goodwin, Daniel J. Fernandes and Robert L. Capizzi in 2010 and is headquartered in Charleston, SC. | 14 anni |
| Jon Olson | M | 61 |
Medical University of South Carolina
| - |
| Gordon Jones | M | - |
Medical University of South Carolina
| - |
| Gerard A. Silvestri | M | - |
Medical University of South Carolina
| - |
| Thomas A. Dix | M | - |
Medical University of South Carolina
| - |
| Jerry R. Youkey | M | 75 |
Medical University of South Carolina
| - |
| David E. Rivers | M | - |
Medical University of South Carolina
| 29 anni |
| James C. Allen | M | - |
Medical University of South Carolina
| - |
| Routt Reigart | M | - |
Medical University of South Carolina
| - |
| Robert M. Sade | M | - |
Medical University of South Carolina
| - |
| Mark S. Sothmann | M | - |
Medical University of South Carolina
| - |
| David Pacitti | M | 58 |
Medical University of South Carolina
| - |
| Timothy Tremont | M | - |
Medical University of South Carolina
| - |
| Srini Srinivas | M | - |
Medical University of South Carolina
| - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Robert L. Capizzi | M | - |
CharlestonPharma LLC
CharlestonPharma LLC Medical SpecialtiesHealth Technology CharlestonPharma LLC develops therapeutic antibodies and related diagnostic tests for cancer patients and healthcare providers. It develops an obtained in vitro, ex vivo and in vivo proof of concept for its first-in-class fully human monoclonal antibodies that specifically target nucleolin located in the plasma membrane and cytoplasm of tumor cells. The company was founded by Bradford S. Goodwin, Daniel J. Fernandes and Robert L. Capizzi in 2010 and is headquartered in Charleston, SC. | 5 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 15 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Daniel J. Fernandes
- Contatti personali
